Continental Advisors LLC maintained its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 10,000 shares of the pharmacy operator’s stock at the end of the first quarter. Continental Advisors LLC’s holdings in Walgreens Boots Alliance were worth $831,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the stock. Chesley Taft & Associates LLC raised its stake in shares of Walgreens Boots Alliance by 1.4% in the first quarter. Chesley Taft & Associates LLC now owns 174,098 shares of the pharmacy operator’s stock valued at $14,459,000 after buying an additional 2,462 shares in the last quarter. Gulf International Bank UK Ltd raised its stake in shares of Walgreens Boots Alliance by 1.8% in the first quarter. Gulf International Bank UK Ltd now owns 286,363 shares of the pharmacy operator’s stock valued at $23,782,000 after buying an additional 4,970 shares in the last quarter. Lynch & Associates IN raised its stake in shares of Walgreens Boots Alliance by 0.3% in the first quarter. Lynch & Associates IN now owns 46,177 shares of the pharmacy operator’s stock valued at $3,835,000 after buying an additional 125 shares in the last quarter. Koshinski Asset Management Inc. raised its stake in shares of Walgreens Boots Alliance by 25.3% in the first quarter. Koshinski Asset Management Inc. now owns 9,109 shares of the pharmacy operator’s stock valued at $756,000 after buying an additional 1,841 shares in the last quarter. Finally, Quadrant Capital Group LLC raised its stake in shares of Walgreens Boots Alliance by 2.8% in the first quarter. Quadrant Capital Group LLC now owns 7,246 shares of the pharmacy operator’s stock valued at $587,000 after buying an additional 200 shares in the last quarter. Hedge funds and other institutional investors own 61.17% of the company’s stock.
Shares of Walgreens Boots Alliance, Inc. (WBA) traded up 0.84% during midday trading on Friday, reaching $80.42. The company’s stock had a trading volume of 1,129,522 shares. The stock has a market capitalization of $86.06 billion, a price-to-earnings ratio of 20.31 and a beta of 1.25. The company has a 50 day moving average of $78.96 and a 200-day moving average of $82.30. Walgreens Boots Alliance, Inc. has a 52 week low of $75.18 and a 52 week high of $89.69.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The business had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. During the same period in the previous year, the business posted $1.18 earnings per share. The business’s revenue was up 2.1% compared to the same quarter last year. Equities research analysts predict that Walgreens Boots Alliance, Inc. will post $5.01 earnings per share for the current year.
Walgreens Boots Alliance declared that its Board of Directors has initiated a share repurchase program on Thursday, June 29th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to purchase up to 5.9% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s leadership believes its stock is undervalued.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.01%. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend is Wednesday, August 16th. Walgreens Boots Alliance’s payout ratio is 37.78%.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.com-unik.info/2017/08/11/continental-advisors-llc-has-831000-position-in-walgreens-boots-alliance-inc-wba.html.
Several analysts have recently commented on WBA shares. Jefferies Group LLC decreased their price objective on Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, May 31st. Zacks Investment Research lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday, June 14th. BidaskClub lowered Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Saturday, June 24th. Needham & Company LLC started coverage on Walgreens Boots Alliance in a research report on Tuesday, June 27th. They issued a “hold” rating on the stock. Finally, Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and issued a $77.00 target price (down from $89.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, June 28th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and fourteen have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $90.69.
In other news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the transaction, the director now directly owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 13.50% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).
What are top analysts saying about Walgreens Boots Alliance Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Walgreens Boots Alliance Inc. and related companies.